Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenues
Operating Expenses
Research and development	2,127,038	2,621,910
General and administrative	5,387,752	3,660,728
Stock-based compensation - general and administrative	2,524,824	3,058,185
Total Operating Expenses	10,039,614	9,340,823
Operating Loss	(10,039,614)	(9,340,823)
Other Income
Interest income	22,608	253,638
Total Other Income	22,608	253,638
Loss before Income Taxes	(10,017,006)	(9,087,185)
Income tax expense	264,240	144,000
Net Loss	(10,281,246)	(9,231,185)
Net loss attributable to non-controlling interest	513,000
Net Loss Applicable to Common Stockholders	$ (9,768,246)	$ (9,231,185)
Net Loss Per Share - Basic (in Dollars per share)	$ (1.3)	$ (1.45)
Net Loss Per Share - Diluted (in Dollars per share)	$ (1.3)	$ (1.45)
Weighted Average Common Shares Outstanding
Basic and diluted (in Shares)	7,492,460	6,358,237
Diluted (in Shares)	7,492,460	6,358,237

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.